| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jianing Chi, Jiaman Hu, Ningxia Wu, Hua Cai, Cailong Lin, Yingying Lai, Jianyu Huang, Weihua Li, Peng Su, Min Li, Lin X. Causal effects for neurodegenerative diseases on the risk of myocardial infarction: a two-sample Mendelian randomization study. Aging. vol 16. 2024-06-08. PMID:38850523. |
this study aimed to investigate the potential causal associations of genetically predicted alzheimer's disease (ad), dementia with lewy bodies (dlb), parkinson's disease (pd), and multiple sclerosis (ms) with mi using two-sample mendelian randomization (tsmr). |
2024-06-08 |
2024-06-11 |
Not clear |
| Blayne Wel. The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review. Indian journal of urology : IJU : journal of the Urological Society of India. vol 40. issue 2. 2024-05-10. PMID:38725892. |
nlutd is prevalent in various conditions, including spinal cord injury (sci), spina bifida (sb), multiple sclerosis (ms), parkinson's, stroke, and dementia and often requires anticholinergic overactive bladder (oab) medications. |
2024-05-10 |
2024-05-27 |
Not clear |
| Igor Y Iskusnykh, Anastasia A Zakharova, Evgenii D Kryl'skii, Tatyana N Popov. Aging, Neurodegenerative Disorders, and Cerebellum. International journal of molecular sciences. vol 25. issue 2. 2024-01-23. PMID:38256091. |
diminished cerebellar function results in the motor and cognitive impairment observed in patients with neurodegenerative disorders such as alzheimer's disease (ad), vascular dementia (vd), parkinson's disease (pd), huntington's disease (hd), spinal muscular atrophy (sma), amyotrophic lateral sclerosis (als), friedreich's ataxia (frda), and multiple sclerosis (ms), and even during the normal aging process. |
2024-01-23 |
2024-01-25 |
Not clear |
| Nilima Khakha, Heena Khan, Amarjot Kaur, Thakur Gurjeet Sing. Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration. Pharmacological reports : PR. 2023-09-09. PMID:37688751. |
the most common neurodegenerative disorders (ndds) include alzheimer's disease (ad), huntington's disease (hd), amyotrophic lateral sclerosis (als), parkinson's disease (pd), multiple sclerosis (ms), motor neuron disorders, psychological disorders, dementia with vascular dementia (vad), lewy body dementia (dlb), epilepsy, cerebral ischemia, mental illness, and behavioral disorders. |
2023-09-09 |
2023-10-07 |
Not clear |
| Ji-Yun Cheng, Yue-Ting Deng, Jin-Tai Y. The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study. Journal of neurochemistry. 2023-08-11. PMID:37565992. |
the potential causalities between nine amino acids (glutamine [glu], leucine [leu], isoleucine [ile], phenylalanine [phe], valine [val], alanine [ala], tyrosine [tyr], histidine [his], and glycine [gly]) and six neurodegenerative disorders (alzheimer's disease [ad], parkinson's disease [pd], multiple sclerosis [ms], frontotemporal dementia [ftd], lewy body dementia [dlb], amyotrophic lateral sclerosis [als]) were explored in this study. |
2023-08-11 |
2023-08-16 |
Not clear |
| Mohammed Salha, Henry Adenusi, John H Dupuis, Enrico Bodo, Bruno Botta, Iain McKenzie, Rickey Y Yada, David H Farrar, Jakob Magolan, Kun V Tian, Gregory A Chas. Bioactivity of the cannabigerol cannabinoid and its analogues - the role of 3-dimensional conformation. Organic & biomolecular chemistry. 2023-05-24. PMID:37222259. |
cannabinoids are naturally occurring bioactive compounds with the potential to help treat chronic illnesses including epilepsy, parkinson's disease, dementia and multiple sclerosis. |
2023-05-24 |
2023-08-14 |
Not clear |
| Hsueh-Sheng Chiang, Alka Khera, Barbara E Stopschinski, Olaf Stuve, John Hart, Brendan Kelley, Trung Nguye. Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature. Geriatrics (Basel, Switzerland). vol 7. issue 3. 2022-06-23. PMID:35735766. |
several important questions regarding cognitive aging and dementia in older people with multiple sclerosis (pwms) are the focus of this narrative review: do older pwms have worse cognitive decline compared to older people without ms? |
2022-06-23 |
2023-08-14 |
Not clear |
| Ping Sun, Milton H Hamblin, Ke-Jie Yi. Non-coding RNAs in the regulation of blood-brain barrier functions in central nervous system disorders. Fluids and barriers of the CNS. vol 19. issue 1. 2022-03-29. PMID:35346266. |
in this review, we have summarized the mirnas, lncrnas, and circrnas that can be served as diagnostic and prognostic biomarkers for bbb injuries, and demonstrated the involvement and underlying mechanisms of ncrnas in modulating bbb structure and function in various cns diseases, including ischemic stroke, hemorrhagic stroke, traumatic brain injury (tbi), spinal cord injury (sci), multiple sclerosis (ms), alzheimer's disease (ad), vascular cognitive impairment and dementia (vcid), brain tumors, brain infections, diabetes, sepsis-associated encephalopathy (sae), and others. |
2022-03-29 |
2023-08-13 |
Not clear |
| Zuhal Abasıyanık, Merve Kurt, Turhan Kahrama. COVID-19 and Physical Activity Behaviour in People with Neurological Diseases: A Systematic Review. Journal of developmental and physical disabilities. 2022-02-07. PMID:35125854. |
the study populations were parkinson disease (n = 7), dementia (n = 1), multiple sclerosis (n = 1), spinal cord injury (n = 1), hereditary spastic paraplegia (n = 1), neuromuscular diseases (n = 1), charcot-marie-tooth neuropathy (n = 1), and epilepsy (n = 1). |
2022-02-07 |
2023-08-13 |
Not clear |
| Daniela Gerovska, Marcos J Araúzo-Brav. The common incidence-age multistep model of neurodegenerative diseases revisited: wider general age range of incidence corresponds to fewer disease steps. Cell & bioscience. vol 12. issue 1. 2022-01-30. PMID:35093175. |
previously, we collected age-stratified incidence data of 404 epidemiological datasets of 10 neurodegenerative diseases (nds), namely amyotrophic lateral sclerosis (als), alzheimer's disease (ad), parkinson's disease (pd), huntington's disease (hd), fronto temporal dementia (ftd), dementia with lewy bodies (dlb), parkinsonism (pdm), parkinson's disease with dementia (pdd), creutzfeldt-jakob disease (cjd), and multiple sclerosis (ms). |
2022-01-30 |
2023-08-13 |
Not clear |
| Walter J Lukiw, Theodore P A Kruck, Maire E Percy, Aileen I Pogue, Peter N Alexandrov, William J Walsh, Nathan M Sharfman, Vivian R Jaber, Yuhai Zhao, Wenhong Li, Catherine Bergeron, Frank Culicchia, Zhide Fang, Donald R C McLachla. Aluminum in neurological disease - a 36 year multicenter study. Journal of Alzheimer's disease & Parkinsonism. vol 8. issue 6. 2020-09-30. PMID:31179161. |
neurological diseases examined were ad (n=186), ataxia friedreich's type (aft; n=6), amyotrophic lateral sclerosis (als; n=16), autism spectrum disorder (asd; n=26), dialysis dementia syndrome (dds; n=27), down's syndrome (ds; trisomy21; n=24), huntington's chorea (hc; n=15), multiple infarct dementia (mid; n=19), multiple sclerosis (ms; n=23), parkinson's disease (pd; n=27), prion disease (prd; n=11) including bovine spongiform encephalopathy (bse; 'mad cow disease'), creutzfeldt-jakob disease (cjd) and gerstmann-straussler-sheinker syndrome (gss), progressive multifocal leukoencephalopathy (pml; n=11), progressive supranuclear palsy (psp; n=24), schizophrenia (scz; n=21), a young control group (ycg; n=22) and an aged control group (acg; n=53). |
2020-09-30 |
2023-08-13 |
human |
| Francesco Tramonti, Luca Bonfiglio, Paolo Bongioanni, Cristina Belviso, Chiara Fanciullacci, Bruno Rossi, Carmelo Chisari, Maria Chiara Carboncin. Caregiver burden and family functioning in different neurological diseases. Psychology, health & medicine. vol 24. issue 1. 2019-07-15. PMID:30141703. |
forty-two primary caregivers of patients with amyotrophic lateral sclerosis (als), alzheimer's disease and other dementia (ad), parkinson's disease (pd), acquired brain injuries (abi) and multiple sclerosis (ms) were administered scales for the evaluation of caregiver burden (cbi) and family functioning (faces iv). |
2019-07-15 |
2023-08-13 |
Not clear |
| Donald R C McLachlan, Catherine Bergeron, Peter N Alexandrov, William J Walsh, Aileen I Pogue, Maire E Percy, Theodore P A Kruck, Zhide Fang, Nathan M Sharfman, Vivian Jaber, Yuhai Zhao, Wenhong Li, Walter J Luki. Aluminum in Neurological and Neurodegenerative Disease. Molecular neurobiology. vol 56. issue 2. 2019-07-11. PMID:30706368. |
neurological diseases examined were alzheimer's disease (ad; n = 186), ataxia friedreich's type (aft; n = 6), amyotrophic lateral sclerosis (als; n = 16), autism spectrum disorder (asd; n = 26), dialysis dementia syndrome (dds; n = 27), down's syndrome (ds; trisomy, 21; n = 24), huntington's chorea (hc; n = 15), multiple infarct dementia (mid; n = 19), multiple sclerosis (ms; n = 23), parkinson's disease (pd; n = 27), and prion disease (prd; n = 11) that included bovine spongiform encephalopathy (bse; "mad cow disease"), creutzfeldt-jakob disease (cjd) and gerstmann-straussler-sheinker syndrome (gss), progressive multifocal leukoencephalopathy (pml; n = 11), progressive supranuclear palsy (psp; n = 24), schizophrenia (scz; n = 21), a young control group (ycg; n = 22; mean age, 10.2 ± 6.1 year), and an aged control group (acg; n = 53; mean age, 71.4 ± 9.3 year). |
2019-07-11 |
2023-08-13 |
human |
| Y C Lai, Y W Yew, W C Lamber. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology : JEADV. vol 30. issue 12. 2017-04-21. PMID:27599898. |
patients with bp were significantly more likely to have stroke (rr 2.68, 95% ci: 2.07-3.46), parkinson's disease (pd; rr 3.42, 95% ci: 3.01-3.87), dementia (rr 4.46, 95% ci: 3.23-6.16), epilepsy (rr 2.98, 95% ci: 1.42-6.28), multiple sclerosis (rr 12.40, 95% ci: 6.64-23.17) and any aforementioned neurological disease (rr 4.93, 95% ci: 3.62-6.70), compared to controls. |
2017-04-21 |
2023-08-13 |
Not clear |
| Patrizia LoPrest. Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases. Neurochemical research. vol 40. issue 11. 2016-08-24. PMID:26394614. |
the cytoskeleton protein tau present in oligodendrocytes (olgs) promotes cellular process outgrowth and myelination; whereas abnormally hyperphosphorylated tau has been shown to be present in the most debilitating form of multiple sclerosis and in selective dementias. |
2016-08-24 |
2023-08-13 |
mouse |
| Ajit G Thomas, Cliona M O'Driscoll, Joseph Bressler, Walter Kaufmann, Camilo J Rojas, Barbara S Slushe. Small molecule glutaminase inhibitors block glutamate release from stimulated microglia. Biochemical and biophysical research communications. vol 443. issue 1. 2014-05-06. PMID:24269238. |
both glutaminase sirna and small molecule inhibitors have been shown to decrease excess glutamate and provide neuroprotection in multiple models of disease, including hiv-associated dementia (had), multiple sclerosis and ischemia. |
2014-05-06 |
2023-08-12 |
Not clear |
| Ajit G Thomas, Camilo Rojas, Cordelle Tanega, Min Shen, Anton Simeonov, Matthew B Boxer, Douglas S Auld, Dana V Ferraris, Takashi Tsukamoto, Barbara S Slushe. Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors. Biochemical and biophysical research communications. vol 438. issue 2. 2013-11-26. PMID:23850693. |
glutaminase catalyzes the hydrolysis of glutamine to glutamate and plays a central role in the proliferation of neoplastic cells via glutaminolysis, as well as in the generation of excitotoxic glutamate in central nervous system disorders such as hiv-associated dementia (had) and multiple sclerosis. |
2013-11-26 |
2023-08-12 |
Not clear |
| Hamdy Na El Tallawy, Wafaa Ma Farghaly, Tarek A Rageh, Ghaydaa A Shehata, Reda Badry, Nabil A Metwally, Esam A El Moselhy, Mahmoud Hassan, Mohamed A Sayed, Ahmed A Waris, Yaser Hamed, Islam Shaaban, Mohamed A Hamed, Mahmoud Raafat Kandi. Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt. Neuropsychiatric disease and treatment. vol 9. 2013-06-10. PMID:23745047. |
the order of frequency of prevalence of the studied neurological disorders was dementia (3.83% for those aged > 60 years), migraine (2.8% for those aged > 8 years), stroke (6.2/1000 for those aged > 20 years), epilepsy (5.5/1000), parkinson's disease (452.1/100,000 for those aged > 40 years), cerebral palsy (3.6/1000 among children < 18 years), spinal cord disorders (63/100,000) dystonia (39.11/100,000), cerebellar ataxia (30.01/100,000), trigeminal neuralgia (28/100,000 for those aged > 37 years), chorea (21.03/100,000), athetosis (15/100,000), and multiple sclerosis (13.74/100,000). |
2013-06-10 |
2023-08-12 |
Not clear |
| Hayrettin Tumani, Charlotte Teunissen, Sigurd Süssmuth, Markus Otto, Albert C Ludolph, Johannes Brettschneide. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert review of molecular diagnostics. vol 8. issue 4. 2008-08-12. PMID:18598229. |
chronic neurological diseases (cnd) like amyotrophic lateral sclerosis (als), dementia or multiple sclerosis (ms) share a chronic progressive course of disease that frequently leads to the common pathological pathway of neurodegeneration, including neuroaxonal damage, apoptosis and gliosis. |
2008-08-12 |
2023-08-12 |
Not clear |
| Pasquale Calabrese, Iris Katharina Penne. Cognitive dysfunctions in multiple sclerosis--a "multiple disconnection syndrome"? Journal of neurology. vol 254 Suppl 2. 2007-10-03. PMID:17503122. |
after giving a brief overview of the cognitive core deficit in multiple sclerosis (ms), pros and cons of considering the clinical characteristics as a form of 'subcortical dementia' are discussed. |
2007-10-03 |
2023-08-12 |
Not clear |